Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Mar;28(3):259-66.
doi: 10.1016/s0145-2126(03)00261-3.

Interleukin-18 in multiple myeloma patients: serum levels in relation to response to treatment and survival

M G Alexandrakis  1 , F H Passam, K Sfiridaki, J Moschandrea, C Pappa, D Liapi, E Petreli, P Roussou, D S Kyriakou
Affiliations

Interleukin-18 in multiple myeloma patients: serum levels in relation to response to treatment and survival

M G Alexandrakis et al. Leuk Res. 2004 Mar.

Abstract

Interleukin-18 (IL-18) plays a role in the host's response to tumours and angiogenesis. We determined serum levels of IL-18, vascular endothelial growth factor (VEGF), angiogenin (ANG), tumor necrosis factor (TNF-alpha) and CRP in 65 newly diagnosed myeloma patients. IL-18, VEGF, angiogenin, TNF-alpha and CRP were significantly higher at stage III in comparison to stages II and I. These cytokines (measured in 27 patients) significantly decreased after treatment. In survival analysis, higher levels of IL-18 were associated with a poorer prognosis. We conclude that increased serum IL-18 in myeloma patients correlates with advanced disease, increased levels of angiogenic cytokines and worse survival.

PubMed Disclaimer

MeSH terms

LinkOut - more resources